ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
40 announcements with these filters
Promoter Jitendrakumar Patel bought 3,00,150 Amanta Healthcare shares off-market for about Rs 5.40 Crore. Promoter holding rises from 9.02% to 9.79%.
Q2 FY27 revenue ₹83.1 Cr (+17%), PAT ₹4.86 Cr (+26%), EBITDA margin 21.6%. The FY27 ₹420–430 Cr target needs a steep H2 ramp the Q2 run-rate doesn't support.
Q2FY27 revenue ₹83.1 Cr (+17.3% YoY), EBITDA ₹17.95 Cr (21.6% margin), PAT ₹4.86 Cr. H1 revenue ₹151.9 Cr, PAT ₹8.2 Cr. SteriPort Line 3 commissioned September 2026.
Amanta Healthcare reported Q2FY27 revenue of ₹83.13 crore and PAT of ₹4.86 crore, both up sharply YoY. SteriPort Line 3 was commissioned, raising bottle capacity to 11.6 crore.
Amanta Healthcare Ltd reported revenue from operations of ₹83.1 Cr (+17.2% YoY) and net profit of ₹4.9 Cr (+308.3% YoY) for Q2 FY27.
Amanta Healthcare's quarterly shareholding pattern as at 30 Sep 2026 shows promoter and promoter group holding at 31.33%. The filing notes a gift-based promoter group addition, but is a routine periodic disclosure.
Amanta Healthcare's COO Shri Anil Rathi resigned effective October 29, 2026. The departure is disclosed under Regulation 30 of the SEBI Listing Regulations.
Amanta Healthcare intimated a Board Meeting scheduled for 3 Nov 2026 to approve Q1 & H1 FY27 unaudited results. Trading window reopens on 6 Nov 2026.
Amanta Healthcare Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Pravinchandra Dhanjibhai Mehta, a promoter group member of Amanta Healthcare, disposed of 17,32,763 equity shares via an off-market gift. His stake decreased from 4.72% to 0.26%.
Promoter Pravinchandra Mehta sold 1,50,400 shares of Amanta Healthcare to fellow promoter Kirit Desai in an off-market inter-se transfer valued at ₹2.86 Crore.
Amanta Healthcare reported an inter-se off-market transfer of 1,50,400 equity shares between promoter group members. Kirit Ambalal Desai acquired the stake valued at ₹2.86 Crore from Pravinchandra Dhanjibhai Mehta.
Pravinchandra Dhanjibhai Mehta and Kirit Ambalal Desai, members of the promoter group, acquired 1,50,400 shares each via off-market inter-se transfers. Both transactions were valued at Rs. 2.86 Crore each.
Amanta Healthcare Limited appointed Nimesh P Patel as Non-Executive Non-Independent Director. The company also appointed M/s. Kashyap R. Mehta & Partners as the Secretarial Auditor.
Amanta Healthcare held its 31st Annual General Meeting on September 16, 2026, transacting ordinary and special business items via video conferencing.
Amanta Healthcare has commenced production at its new SteriPort facility at the Kheda campus. This brownfield expansion aims to improve operational efficiency and EBITDA margins.
Amanta Healthcare Ltd has provided a web-link for shareholders to access the Annual Report and Notice of the 31st Annual General Meeting.
Amanta Healthcare Limited has scheduled its 31st Annual General Meeting for September 16, 2026. Key agenda items include adopting financial statements and revising the Managing Director's remuneration.
Amanta Healthcare Limited has issued a notice for its 31st Annual General Meeting scheduled for September 16, 2026. Key agenda items include adopting financial statements and auditor appointments.
Amanta Healthcare Limited has released its Annual Report for FY 2025-26. The company will hold its 31st Annual General Meeting on September 16, 2026, via video conferencing.
Amanta Healthcare delivers solid FY26 results with significant profit growth, transitioning toward high-margin specialized products like Steriport and ophthalmic solutions.
Amanta Healthcare reported Q1FY27 revenue of Rs.68.8 Crore with EBITDA of Rs.15.2 Crore. Profitability was impacted by higher finance costs for new projects.
Amanta reported Q1FY27 revenue of INR 69 Cr (5% YoY) with 21% EBITDA margins. Strategy focuses on high-margin SteriPort/SVP capacity expansion and cost optimization via solar power.
Amanta Healthcare Limited submitted the Statement of Deviation in fund utilization for the quarter ended June 30, 2026, confirming no deviation in usage of IPO proceeds.
Amanta Healthcare Ltd reported revenue from operations of ₹68.8 Cr (+5.4% YoY) and net profit of ₹3.3 Cr (-5.7% YoY) for Q1 FY27.
Amanta Healthcare Ltd has appointed Mr. Nilesh Punjabi as Assistant Vice President (HR & Admin) and Senior Management Personnel, effective August 5, 2026.
Amanta Healthcare has scheduled a board meeting on August 5, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Amanta Healthcare Ltd has filed its quarterly shareholding pattern for the period ended June 30, 2026, as required under SEBI (LODR) Regulations.
Promoter Bhavesh G Patel acquired 1,000 shares from Kirit Desai via off-market transfer for ₹0.0016 Crore. The acquisition occurred on June 30, 2026.
Promoter Bhavesh Girishbhai Patel acquired 1,000 shares via an off-market inter-se transfer. The transaction value totaled 0.016 Crore at the specified price.